Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The Use of Acute Immunosuppressive Therapy to Improve Antibiotic Efficacy against Intracellular Staphylococcus aureus

Microbiology Spectrum(2022)10.1128/spectrum.00858-22Source: DataRank Database

The Use of Acute Immunosuppressive Therapy to Improve Antibiotic Efficacy against Intracellular Staphylococcus aureus is a research paper published in Microbiology Spectrum (2022). On theSindex it has a DataRank of 0. It has been cited 11 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access11 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 0.97)OA: goldTopics (40)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Sophie Maiocchi ORCID,Ana Cartaya ORCID,Sarah E. Rowe ORCID,Edward Moreira Bahnson ORCID,Brian P. Conlon ORCID

Live enrichment

PubMed:35575507 OpenAlex:https://openalex.org/W4280493612

Burroughs Wellcome Fund

Grant: PATH

HHS | National Institutes of Health

Grant: R01AI137273

HHS | National Institutes of Health

Grant: R03AI148822

National Institutes of Health

Grant: 1R03AI148822-01

Engineering Staphylococcus aureus to sense and record oxidative stress

National Institutes of Health

Grant: 3R01AI137273-02S1

Antibiotic activities against S. aureus during P. aeruginosa co-infection

NHLBI NIH HHS

Grant: F31 HL156427

NHLBI NIH HHS

Grant: K01 HL145354

FWCI

0.97

Citation Percentile

0.8%

Citation Trend

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://doi.org/10.1128/spectrum.00858-22

publisherhttps://doi.org/10.1128/spectrum.00858-22

publisherhttps://journals.asm.org/doi/pdf/10.1128/spectrum.00858-22

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35575507

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9241675

Fields of Study

Antimicrobial Resistance in StaphylococcusImmune Response and InflammationAntimicrobial Peptides and Activities0301 basic medicine0303 health sciences03 medical and health sciencesAnti-Bacterial AgentsBacteremiaHumansImmunosuppression TherapyReactive Oxygen SpeciesStaphylococcal InfectionsStaphylococcus aureus

MeSH Terms

Anti-Bacterial AgentsHumansImmunosuppression TherapyStaphylococcal InfectionsStaphylococcus aureusBacteremiaReactive Oxygen Species

Keywords

Staphylococcus aureusBacteremiaAntibioticsAntibiotic therapyMedicineIntracellularMicrobiologyStaphylococcal infectionsIntensive care medicineImmunologyBiologyBacteriareactive oxygen speciesImmunosuppression TherapyObservationimmunomodulationQR1-502Anti-Bacterial Agentspersister cellsHumans

Sustainable Development Goals

SDG 3: 3. Good health